Steven Cohen’s Bristol-Myers Squibb BMY Stock Holding History

Steven Cohen’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$22.3M	Buy	387,300 +210,000	+118%	+$12.1M	0.02%	821
2026 Q1	$10.8M	Buy	177,300 +157,400	+791%	+$9.18M	0.01%	1198
2025 Q4	$1.07M	Sell	19,900 -34,600	-63%	-$1.66M	﹤0.01%	2834
2025 Q3	$2.46M	Buy	+54,500	New	+$2.55M	﹤0.01%	1352
2025 Q2	–	Sell	-17,100	Closed	-$1.04M	–	2202
2025 Q1	$1.04M	Buy	+17,100	New	+$997K	﹤0.01%	1433
2024 Q2	–	Sell	-2,100	Closed	-$114K	–	1888
2024 Q1	$114K	Sell	2,100 -300	-13%	-$15.3K	﹤0.01%	1988
2023 Q4	$123K	Hold	2,400	–	–	﹤0.01%	1907
2023 Q3	$139K	Hold	2,400	–	–	﹤0.01%	1872
2023 Q2	$153K	Sell	2,400 -50,200	-95%	-$3.37M	﹤0.01%	1481
2023 Q1	$3.65M	Sell	52,600 -53,200	-50%	-$3.75M	0.01%	850
2022 Q4	$7.61M	Buy	105,800 +33,700	+47%	+$2.54M	0.03%	634
2022 Q3	$5.13M	Buy	+72,100	New	+$5.23M	0.02%	718
2020 Q3	–	Sell	-1,000,000	Closed	-$58.8M	–	927
2020 Q2	$58.8M	Buy	+1,000,000	New	+$59.8M	0.38%	63
2017 Q3	–	Sell	-500,000	Closed	-$27.9M	–	886
2017 Q2	$27.9M	Buy	+500,000	New	+$27.2M	0.16%	177
2016 Q1	–	Sell	-117,500	Closed	-$8.08M	–	731
2015 Q4	$8.08M	Buy	+117,500	New	+$7.76M	0.07%	338

Other funds holding BMY

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Norges Bank Oslo, Norway $1T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Steven Cohen's BMY Position: Q2 2026 in Review

Steven Cohen sold out of Bristol-Myers Squibb (BMY) in Q2 2026, closing a stake of 531,198 shares — an estimated $30.5M sold.

Steven Cohen first reported a position in BMY in Q2 2014 and held it in 33 quarters. The position peaked at $189M in Q2 2018. 2,506 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

Steven Cohen reported no remaining Bristol-Myers Squibb position as of Q2 2026 after selling out during the quarter.
Steven Cohen sold 531,198 Bristol-Myers Squibb shares in Q2 2026, an estimated $30.5M.
Steven Cohen first reported a position in Bristol-Myers Squibb in Q2 2014 and held it in 33 quarters.
Steven Cohen's Bristol-Myers Squibb position peaked at $189M in Q2 2018.
2,506 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on Point72 Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.